Clinical Trials
We are evaluating our lead regulatory T cell (Treg) product in clinical trials. This is a critical step in making our hope of finding a cure a reality.
Regulate-RA
We have initiated a Phase 1 study of our lead cell therapy candidate, SBT-77-7101, in patients with rheumatoid arthritis.For more information Regulate-RA, please visit our clinical trial website.
Learn MoreRegulate-HS
We have also initiated a Phase 1 study of 7101 in patients with hidradenitis suppurativa.For more information about Regulate-HS please visit our clinical trial website.
Learn More